CVS Health Co. (NYSE:CVS) Stock Holdings Decreased by Cetera Trust Company N.A

Cetera Trust Company N.A trimmed its position in CVS Health Co. (NYSE:CVS) by 6.5% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 17,043 shares of the pharmacy operator’s stock after selling 1,190 shares during the period. Cetera Trust Company N.A’s holdings in CVS Health were worth $1,072,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Livelsberger Financial Advisory acquired a new position in CVS Health in the third quarter worth $31,000. Crewe Advisors LLC acquired a new position in shares of CVS Health in the 1st quarter valued at about $40,000. Retirement Group LLC grew its position in shares of CVS Health by 54.3% during the 1st quarter. Retirement Group LLC now owns 517 shares of the pharmacy operator’s stock valued at $41,000 after buying an additional 182 shares during the last quarter. Kathleen S. Wright Associates Inc. acquired a new stake in CVS Health during the third quarter worth about $33,000. Finally, First Community Trust NA lifted its holdings in CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after acquiring an additional 302 shares during the last quarter. 80.66% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

CVS has been the subject of several recent research reports. Evercore ISI upped their target price on CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th. TD Cowen upgraded CVS Health from a “hold” rating to a “buy” rating and upped their price objective for the stock from $59.00 to $85.00 in a research note on Friday, October 4th. Barclays raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $63.00 to $82.00 in a report on Thursday, October 10th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $68.00 price objective on shares of CVS Health in a report on Wednesday, September 4th. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Nine research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and an average target price of $75.26.

CVS Health Price Performance

Shares of CVS traded down $1.03 during mid-day trading on Tuesday, hitting $57.14. The company’s stock had a trading volume of 3,901,572 shares, compared to its average volume of 11,202,447. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. The firm has a 50-day moving average price of $59.85 and a 200 day moving average price of $60.32. CVS Health Co. has a fifty-two week low of $52.77 and a fifty-two week high of $83.25. The stock has a market capitalization of $71.73 billion, a price-to-earnings ratio of 10.22, a PEG ratio of 0.93 and a beta of 0.54.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.73 by $0.10. The company had revenue of $91.23 billion for the quarter, compared to analysts’ expectations of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The firm’s revenue was up 2.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.21 earnings per share. On average, research analysts predict that CVS Health Co. will post 6.51 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Monday, October 21st will be issued a dividend of $0.665 per share. The ex-dividend date is Monday, October 21st. This represents a $2.66 annualized dividend and a yield of 4.66%. CVS Health’s payout ratio is presently 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.